376 related articles for article (PubMed ID: 31492174)
61. HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report.
Esteves G; Ferreira J; Afonso R; Martins C; Zagalo C; Félix A
Head Neck Pathol; 2020 Dec; 14(4):1117-1122. PubMed ID: 31989434
[TBL] [Abstract][Full Text] [Related]
62. Sinonasal NUT midline carcinoma: A new histological entity.
Vakani PN; Maheshwari J; Maheshwari M; Shah B
Indian J Pathol Microbiol; 2020; 63(1):103-105. PubMed ID: 32031134
[TBL] [Abstract][Full Text] [Related]
63. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
64. NUT midline carcinoma mimicking a germ cell tumor: a case report.
Harada Y; Koyama T; Takeuchi K; Shoji K; Hoshi K; Oyama Y
BMC Cancer; 2016 Nov; 16(1):895. PubMed ID: 27855672
[TBL] [Abstract][Full Text] [Related]
65. Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive
Zhou J; Duan M; Jiao Q; Chen C; Xing A; Su P; Tang J; Zhang H; Liu Z
Front Oncol; 2021; 11():778296. PubMed ID: 35127482
[TBL] [Abstract][Full Text] [Related]
66. NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H; French CA; Bishop JA; Coca-Pelaz A; Propst EJ; Paiva Correia A; Ngan BY; Grant R; Cipriani NA; Vokes D; Henrique R; Pardal F; Vizcaino JR; Rinaldo A; Ferlito A
Histopathology; 2017 May; 70(6):861-868. PubMed ID: 27926786
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
Chen M; Li S; Jiang L
Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
[TBL] [Abstract][Full Text] [Related]
68. YAP1-NUTM1 Gene Fusion in Porocarcinoma of the External Auditory Canal.
Agaimy A; Tögel L; Haller F; Zenk J; Hornung J; Märkl B
Head Neck Pathol; 2020 Dec; 14(4):982-990. PubMed ID: 32436169
[TBL] [Abstract][Full Text] [Related]
69. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.
Grayson AR; Walsh EM; Cameron MJ; Godec J; Ashworth T; Ambrose JM; Aserlind AB; Wang H; Evan G; Kluk MJ; Bradner JE; Aster JC; French CA
Oncogene; 2014 Mar; 33(13):1736-1742. PubMed ID: 23604113
[TBL] [Abstract][Full Text] [Related]
70. NUT Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
71. The primary pulmonary NUT carcinomas and some uncommon somatic mutations identified by next-generation sequencing: a case report.
Liu Y; Li YY; Ke XX; Lu Y
AME Case Rep; 2020; 4():24. PubMed ID: 33178996
[TBL] [Abstract][Full Text] [Related]
72. NUT midline carcinoma.
French CA
Cancer Genet Cytogenet; 2010 Nov; 203(1):16-20. PubMed ID: 20951314
[TBL] [Abstract][Full Text] [Related]
73. NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features.
Jung M; Kim SI; Kim JW; Jeon YK; Lee C
Int J Gynecol Pathol; 2022 May; 41(3):292-297. PubMed ID: 34166280
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma.
Xie M; Fu X; Wang W
Cancer Med; 2021 Sep; 10(17):5757-5764. PubMed ID: 34409758
[TBL] [Abstract][Full Text] [Related]
75. Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations.
Sholl LM; Nishino M; Pokharel S; Mino-Kenudson M; French CA; Janne PA; Lathan C
J Thorac Oncol; 2015 Jun; 10(6):951-9. PubMed ID: 26001144
[TBL] [Abstract][Full Text] [Related]
76. NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case.
Agaimy A; Tögel L; Stoehr R; Meidenbauer N; Semrau S; Hartmann A; Mantsopoulos K
Virchows Arch; 2021 Dec; 479(6):1095-1099. PubMed ID: 33891143
[TBL] [Abstract][Full Text] [Related]
77.
Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
[TBL] [Abstract][Full Text] [Related]
78. NUT midline carcinoma of the parotid gland with mesenchymal differentiation.
den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ
Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446
[TBL] [Abstract][Full Text] [Related]
79. Challenging Diagnosis in NUT Carcinoma.
Claudia G; Alexandra G
Int J Surg Pathol; 2021 Oct; 29(7):722-725. PubMed ID: 34106022
[TBL] [Abstract][Full Text] [Related]
80. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.
Wang R; Liu W; Helfer CM; Bradner JE; Hornick JL; Janicki SM; French CA; You J
Cancer Res; 2014 Jun; 74(12):3332-43. PubMed ID: 24736545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
